Zibuyu Group Ltd
HKEX:2420
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zibuyu Group Ltd
HKEX:2420
|
CN |
|
PKSHA Technology Inc
TSE:3993
|
JP |
|
M
|
Modern Healthcare Technology Holdings Ltd
HKEX:919
|
HK |
|
InnoCare Pharma Ltd
SSE:688428
|
CN |
|
S
|
Silk Road Logistics Holdings Ltd
HKEX:988
|
HK |
|
PTC Industries Ltd
BSE:539006
|
IN |
|
Indo Us Bio-Tech Ltd
BSE:541304
|
IN |
|
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
US |
|
C
|
Cubex Tubings Ltd
NSE:CUBEXTUB
|
IN |
Income Statement
Earnings Waterfall
Zibuyu Group Ltd
Income Statement
Zibuyu Group Ltd
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
14
|
13
|
9
|
9
|
8
|
0
|
0
|
|
| Revenue |
3 066
N/A
|
3 164
+3%
|
3 000
-5%
|
3 087
+3%
|
3 325
+8%
|
3 824
+15%
|
4 660
+22%
|
|
| Gross Profit | ||||||||
| Cost of Revenue |
(719)
|
(784)
|
(1 045)
|
(1 052)
|
(854)
|
(960)
|
(1 173)
|
|
| Gross Profit |
2 348
N/A
|
2 380
+1%
|
1 955
-18%
|
2 035
+4%
|
2 471
+21%
|
2 864
+16%
|
3 487
+22%
|
|
| Operating Income | ||||||||
| Operating Expenses |
(2 215)
|
(2 315)
|
(2 208)
|
(2 211)
|
(2 334)
|
(2 709)
|
(3 211)
|
|
| Selling, General & Administrative |
(2 222)
|
(2 320)
|
(2 202)
|
(2 212)
|
(2 330)
|
(2 712)
|
(3 212)
|
|
| Depreciation & Amortization |
(6)
|
0
|
(8)
|
0
|
(6)
|
0
|
(5)
|
|
| Other Operating Expenses |
13
|
5
|
2
|
2
|
2
|
3
|
7
|
|
| Operating Income |
133
N/A
|
65
-51%
|
(253)
N/A
|
(176)
+30%
|
137
N/A
|
155
+13%
|
277
+78%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(2)
|
1
|
7
|
12
|
20
|
16
|
1
|
|
| Non-Reccuring Items |
(4)
|
(2)
|
(1)
|
(0)
|
(2)
|
(3)
|
(3)
|
|
| Total Other Income |
1
|
3
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
127
N/A
|
66
-48%
|
(247)
N/A
|
(165)
+33%
|
155
N/A
|
169
+9%
|
275
+63%
|
|
| Net Income | ||||||||
| Tax Provision |
(16)
|
(7)
|
(19)
|
(20)
|
(4)
|
(4)
|
(6)
|
|
| Income from Continuing Operations |
111
|
60
|
(266)
|
(185)
|
151
|
165
|
269
|
|
| Net Income (Common) |
111
N/A
|
60
-46%
|
(266)
N/A
|
(185)
+31%
|
151
N/A
|
165
+10%
|
269
+63%
|
|
| EPS (Diluted) |
0.24
N/A
|
0.14
-42%
|
-0.53
N/A
|
-0.37
+30%
|
0.31
N/A
|
0.34
+10%
|
0.55
+62%
|
|